Science

Apr 10, 2025, 10:49

Myeloma Paper of the Day, April 10th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in myeloma includes higher risk of prolonged transfusion dependence for both pRBC and G-CSF us, as well as higher thrombopoietin receptor agonist use.”

“Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma”

Authors: Joshua Gustine, Andrew Branagan, Diana Cirstea, Farah Rexha, Ryan Han, Andrew Yee, Marcela Maus, Matthew Frigault, Noopur Raje.

More posts featuring Robert Orlowski.

Andrew Branagan Andrew Yee BCMA CAR-T cell therapy cancer clonal hematopoiesis Diana Cirstea Farah Rexha Joshua Gustine Marcela Maus Matthew Frigault multiple myeloma Myeloma Paper of the Day Noopur Raje OncoDaily Oncology Robert Orlowski Ryan Han

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

John Cena Announces He Overcame Skin Cancer Twice, Advocates for Sun Safety

William N. Hait to Receive 2025 AACR-Margaret Foti Award for Leadership in Cancer Research

Stella Kyriakides joins ESO as Co-Chair and Senior Lecturer in Cancer Policy to Guide the 2026–2028 Strategic Plan

FDA Approves Nivolumab and Ipilimumab for Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer: CheckMate 8HW trial results